Figure 7

Prediction of immuno- and chemo-therapy efficacy in COAD patients. Notes: (A) The difference in TIDE between the risk groups. (B) Comparison of immunotherapy response numbers between the two risk patients. (C) Submap analysis for HDAC-related signature in COAD. (D) Box plots of estimated 8 chemotherapeutic agent-drug sensitivity in the risk groups. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.